Depending upon project scope, Iasis Partners calls upon carefully chosen and respected firms and individuals. Our key partners in drug development projects include: 


Sandra L. Morseth, Ph.D.

Expert in Toxicology and Preclinical Drug Development

Dr. Morseth specializes in the science and strategy of preclinical drug development, and brings to our clients over 30 years' experience in government and private industry.  In the past, she served as study director for developmental and reproductive studies at Hazleton Labs (now Covance), and then joined FDA where she was a member of several intercenter committees including Chair of FDA's Developmental and Reproductive Toxicity committee.  After leaving FDA, she again joined Covance as Associate Director of Toxicology, and then served at Quintiles and later at Milestone Biomedical Associates as a preclinical consultant before establishing herself as an independent consultant.  Dr. Morseth received her Ph.D. in Experimental Psychology from Washington State University.  

William G. Kramer, Ph.D.

Expert in Clinical Pharmacology, Pharmacokinetics and Pharmacodynamics

Dr. Kramer has over 35 years' experience in the pharmaceutical industry and academic research.  He assists our clients in program design, protocol preparation, study implementation, and the analysis and interpretation of results, and has prepared pharmacokinetic sections of INDs, NDAs, BLAs, and submissions to European regulatory agencies.  Prior to becoming an independent consultant, Dr. Kramer was Senior Consultant at Quintiles Consulting and, before that, served as Director, Clinical Research, and Head, Pharmacokinetics and Bioanalytics, at Boehringer Mannheim where he created and maintained the pharmacokinetic plan for all drug projects in the U.S.  He also served in the Department of Drug Metabolism and Pharmacokinetics at Schering-Plough Corporation, and spent ten years teaching and conducting clinical pharmacokinetic research at the University of Houston College of Pharmacy.  Dr. Kramer received his Ph.D. in Pharmaceutics from Ohio State University and a B.S. in Pharmacy from the University of Pittsburgh.  

Yuxin Zhang, Ph.D.

Expert in Statistics, Statistical Programming, and Data Management

Dr. Zhang brings more than 25 years’ industry experience to our clients encompassing all aspects of clinical trial design, data collection and statistical analysis and reporting, as well as preparation of registration dossiers, and covering a wide variety of therapeutic areas.  He has served as either sole or lead statistician for five successful NDAs.  Prior to providing independent statistical consulting services, Dr. Zhang served at Shire Pharmaceuticals, where he established and headed its U.S. Biometrics Department and served as Senior Director responsible for biostatistics, statistical programming, data management, and clinical study report preparation, as well as regulatory interactions for biometrics.  Earlier in his career, Dr. Zhang served as a researcher at the University of Maryland and taught experimental design and statistical methods at Beijing University.  He has authored or co-authored numerous peer-reviewed publications.  Dr. Zhang received his Ph.D. in Experimental Psychology from the University of Edinburgh in the United Kingdom, and a B.Sc. in Psychology from Beijing University in China.  

Iasis Partners has also established reciprocal affiliations with expert individuals and firms to provide additional services including clinical operations and data management.  To find out more, or to discuss a prospective project, please click here: